MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202421027890 A) filed by BDR Pharmaceuticals International Private Limited, Maharashtra, on April 4, 2024, for 'pharmaceutical composition of relugolix tablet.'
Inventor(s) include Shah, Dharmesh Mahendrabhai; Badiger, Aravind Manappa; Upadhye, Abhijeet Ashokrao; Patel, Ketul Harshadbhai; Yadav, Sandeep Tarachand; Patil, Kishor Prakashrao; and Khatri, Kamal Rameshbhai.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel oral solid pharmaceutical formulation of relugolix or pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipient. In addition, the present invention also provides an improved process for preparation of relugolix oral solid pharmaceutical formulation. In addition, the present invention also provides better dissolution profile of relugolix oral solid dosage form."
Disclaimer: Curated by HT Syndication.
